ClinicalTrials.Veeva

Menu

Pulsatility Index, Vasomotor Reactivity and Leukoencephalopathy in Fabry Patients

N

National and Kapodistrian University of Athens

Status

Completed

Conditions

Fabry Disease

Treatments

Diagnostic Test: Transcranial Doppler (TCD) and Transcranial Color-Coded Duplex (TCCD) ultrasonography

Study type

Observational

Funder types

Other

Identifiers

NCT04577170
FD29092020

Details and patient eligibility

About

We hypothesize that Fabry disease - FD is associated with elevated vascular resistance induced by cerebral small-vessel disease, indicating increased distal resistance to blood flow. The findings of this study may be used as a precursor for neuroimaging manifestations related to stroke in FD patients.

Enrollment

45 patients

Sex

All

Ages

16 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Fabry disease diagnosis, genetically confirmed Age> 16 years

Exclusion criteria

Insufficient temporal bone window MRI contra-indication Inability to cooperate for breath-holding test Detection of atrial fibrillation Refuse to sing informed consent

Trial design

45 participants in 2 patient groups

Fabry disease
Treatment:
Diagnostic Test: Transcranial Doppler (TCD) and Transcranial Color-Coded Duplex (TCCD) ultrasonography
Healthy
Description:
age and sex matched
Treatment:
Diagnostic Test: Transcranial Doppler (TCD) and Transcranial Color-Coded Duplex (TCCD) ultrasonography

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems